Finance

Lists
Why is MDMA down १०.००%?
Dive Deeper
MDMA:CNSX
Pharmala Biotech Holdings Inc
CA$ ०.१८
-१०.००%
(-०.०२०) 1D
अक्टोबर १५, १४:००:०० GMT-४  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDMA...
Open
CA$ ०.२०
High
CA$ ०.२०
Low
CA$ ०.१८
Mkt. cap
१.९५ करोड
Avg. vol.
१.६४ लाख
Volume
२.१० लाख
52-wk high
CA$ ०.३३
52-wk low
CA$ ०.०८
EPS
-CA$ ०.०२
No. of employees
३
Open
CA$ ०.२०
High
CA$ ०.२०
Low
CA$ ०.१८
Mkt. cap
१.९५ करोड
Avg. vol.
१.६४ लाख
Volume
२.१० लाख
52-wk high
CA$ ०.३३
52-wk low
CA$ ०.०८
EPS
-CA$ ०.०२
No. of employees
३
News stories
From web sources and news partners
About Pharmala Biotech Holdings Inc
CEO-
Employees३
Founded२०२१
Headquartersटोरन्टो, ओन्टारियो, क्यानाडा
Sector-
Websitepharmala.ca
Last report
२०२६ जुलाई २९
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
५.१३ लाख / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
२०२५ अगस्ट
२०२५ नोभेम्बर
२०२६ फेब्रुअरी
२०२६ मे
Revenue
२.६७ लाख
२.०६ लाख
२.८१ लाख
५.१३ लाख
Cost of goods sold
३४.०४ हजार
३४.८४ हजार
२२.४१ हजार
१.७५ लाख
Cost of revenue
३४.०४ हजार
३४.८४ हजार
२२.४१ हजार
१.७५ लाख
Research and development expenses
४४.९१ हजार
४१.१० हजार
४०.५३ हजार
४४.९१ हजार
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.०५ लाख
३.२१ लाख
३.६७ लाख
४.७२ लाख
Operating expense
५.५३ लाख
४.९८ लाख
५.६० लाख
८.११ लाख
Total operating expenses
५.८८ लाख
५.३३ लाख
५.८२ लाख
९.८५ लाख
Operating income
-३.२० लाख
-३.२७ लाख
-३.०२ लाख
-४.७२ लाख
Other non operating income
-४१.०० हजार
-१६.८४ हजार
-४६.१८ हजार
-४०.९७ हजार
EBT including unusual items
-३.६१ लाख
-४.१० लाख
-३.३८ लाख
-५.०० लाख
EBT excluding unusual items
-३.६१ लाख
-३.४४ लाख
-३.४८ लाख
-५.१३ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३.६१ लाख
-४.१० लाख
-३.३८ लाख
-५.०० लाख
Net profit margin
-१३५.०७%
-१९८.४६%
-१२०.३५%
-९७.३७%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
२९.१९ हजार
२९.७६ हजार
२९.७४ हजार
३०.०२ हजार
EBITDA
-३.०७ लाख
-३.१३ लाख
-२.८८ लाख
-४.५८ लाख
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू